-
Homepagina
-
Hip
-
Knee
-
Ankle
-
Shoulder
-
Elbow
-
Wrist
-
Finger
-
Data Quality
Revision per component
- Cemented primary THA – overall revision
- Uncemented primary THA – overall revsion
- Cemented primary THA – major revision
- Uncemented primary THA – major revision
- Bone cement THA
- THA by ODEP 5A or higher acetabulum
- THA by ODEP 5A or higher femur
- THA by cemented material acetabulum
- THA by uncemented material inlay
- THA by cemented material femur
- THA by uncemented material femur
- THA by modularity
Hip » Survival » Revision per component » Cemented primary THA – overall revision
TABLE Cumulative revision percentages of cemented primary total hip arthroplasties by prosthesis component combination of patients who underwent a THA for osteoarthritis in the Netherlands in 2007-2021 (n=82,092)
Type of revision (n) | Cumulative revision percentage (95% CI) | ||||||||||||||||||
Femur component | Acetabulum component | Total primary THAs (n) | Median (IQR) age (yr) | Total revision arthroplasties (n) | Total hip (complete revision) | Only femur component | Only acetabulum component | Only femoral head/inlay | Missing/ unknown | 1yr | 3yr | 5yr | 7yr | 10yr | 13yr | ||||
All cemented THAs for osteoarthritis | 82,092 | 76 (71-81) | 2,345 | 461 | 241 | 958 | 645 | 40 | 1.3 (1.2-1.4) | 2.0 (1.9-2.1) | 2.6 (2.4-2.7) | 3.0 (2.9-3.1) | 3.7 (3.6-3.9) | 4.6 (4.3-4.9) | |||||
Lubinus SPII | IP Cup | 14,118 | 76 (72-81) | 362 | 54 | 46 | 161 | 96 | 5 | 1.1 (0.9-1.3) | 2.0 (1.7-2.2) | 2.5 (2.2-2.8) | 2.8 (2.5-3.1) | 3.2 (2.8-3.5) | 4.0 (3.4-4.7) | ||||
Original ME Muller | Muller low profile Durasul | 8,498 | 75 (70-80) | 225 | 28 | 5 | 49 | 140 | 3 | 1.8 (1.5-2.1) | 2.3 (1.9-2.6) | 2.7 (2.4-3.1) | 3.0 (2.6-3.5) | 3.7 (3.1-4.3) | 3.9 (3.2-4.7) | ||||
Original ME Muller | Muller low profile | 6,324 | 77 (73-81) | 176 | 24 | 2 | 103 | 41 | 6 | 1.4 (1.1-1.7) | 2.4 (2.0-2.8) | 2.7 (2.3-3.1) | 3.1 (2.6-3.5) | 3.1 (2.6-3.5) | 3.3 (2.8-3.9) | ||||
Lubinus SPII | FAL Cup | 5,760 | 75 (70-80) | 186 | 42 | 11 | 70 | 58 | 5 | 1.9 (1.5-2.2) | 2.5 (2.1-2.9) | 3.1 (2.7-3.6) | 3.8 (3.2-4.4) | 4.5 (3.7-5.2) | 5.1 (4.0-6.2) | ||||
Spectron EF | Reflection All Poly XLPE | 4,878 | 77 (73-81) | 112 | 37 | 13 | 40 | 22 | 0 | 0.6 (0.4-0.9) | 1.4 (1.1-1.8) | 1.8 (1.4-2.2) | 2.6 (2.1-3.0) | 2.8 (2.3-3.4) | 3.0 (2.4-3.6) | ||||
Exeter | Exeter Rimfit X3 | 4,664 | 75 (69-80) | 99 | 24 | 20 | 22 | 33 | 0 | 1.4 (1.0-1.7) | 1.9 (1.5-2.3) | 2.4 (1.9-2.9) | 2.4 (1.9-2.9) | 2.6 (2.0-3.1) | n.a. | ||||
Stanmore | Stanmore | 3,374 | 75 (70-80) | 73 | 25 | 2 | 39 | 5 | 2 | 0.7 (0.4-1.0) | 1.4 (1.0-1.8) | 1.9 (1.4-2.3) | 2.0 (1.5-2.5) | 2.5 (1.9-3.1) | 2.7 (2.0-3.4) | ||||
Exeter | Exeter Contemporary Hooded | 2,827* | 77 (72-81) | 95 | 22 | 20 | 36 | 14 | 3 | 1.2 (0.8-1.6) | 1.7 (1.2-2.2) | 2.3 (1.7-2.9) | 2.9 (2.3-3.6) | 4.2 (3.3-5.1) | 4.7 (3.6-5.8) | ||||
Lubinus SPII | SHP | 2,506* | 75 (71-80) | 45 | 9 | 3 | 32 | 1 | 0 | 0.2 (0.0-0.4) | 0.7 (0.3-1.0) | 1.0 (0.6-1.3) | 1.7 (1.2-2.2) | 2.0 (1.4-2.6) | 2.1 (1.5-2.7) | ||||
Exeter | Exeter | 2,447* | 73 (68-79) | 142 | 23 | 14 | 70 | 31 | 4 | 2.8 (2.1-3.4) | 3.6 (2.8-4.3) | 4.1 (3.3-4.9) | 4.9 (4.0-5.7) | 6.2 (5.2-7.3) | 7.0 (5.8-8.2) | ||||
Exeter | Exeter Contemporary Flanged | 2,436 | 75 (67-80) | 77 | 17 | 9 | 40 | 9 | 2 | 0.8 (0.4-1.1) | 1.4 (0.9-1.9) | 2.0 (1.4-2.6) | 2.3 (1.7-3.0) | 3.3 (2.5-4.2) | 5.0 (3.6-6.3) | ||||
Stanmore | SHP | 2,097* | 75 (71-79) | 115 | 39 | 5 | 60 | 10 | 1 | 1.6 (1.0-2.1) | 3.1 (2.3-3.8) | 4.0 (3.2-4.9) | 4.8 (3.8-5.7) | 5.8 (4.7-6.9) | 8.1 (6.4-9.9) | ||||
CCA stem | CCB cup Low Profile | 1,768 | 77 (73-80) | 55 | 8 | 4 | 13 | 29 | 1 | 2.1 (1.4-2.7) | 2.6 (1.8-3.3) | 2.9 (2.1-3.7) | 3.2 (2.3-4.1) | 4.2 (2.9-5.5) | 4.7 (3.1-6.4) | ||||
Stanmore | Exceed ABT Cemented | 1,273 | 76 (71-81) | 22 | 4 | 1 | 8 | 9 | 0 | 1.0 (0.5-1.6) | 1.5 (0.8-2.2) | 1.8 (0.9-2.6) | 3.0 (1.3-4.6) | n.a. | n.a. | ||||
C-Stem AMT | Marathon | 1,133 | 80 (74-83) | 16 | 0 | 2 | 0 | 14 | 0 | 1.2 (0.5-1.8) | 1.7 (0.8-2.5) | n.a. | n.a. | n.a. | n.a. | ||||
Original ME Muller | Avantage Cemented | 1,105 | 77 (71-82) | 41 | 2 | 1 | 3 | 35 | 0 | 3.3 (2.2-4.4) | 3.9 (2.6-5.1) | 4.8 (3.0-6.5) | 5.6 (3.2-8.0) | n.a. | n.a. | ||||
Lubinus SPII | IP Cup X-Linked | 1,083 | 77 (72-82) | 28 | 7 | 3 | 6 | 12 | 0 | 1.6 (0.9-2.4) | 2.5 (1.5-3.5) | 3.4 (2.1-4.7) | 3.4 (2.1-4.7) | n.a. | n.a. | ||||
Stanmore | All Poly Arcom Cup | 1,056* | 74 (69-79) | 21 | 3 | 4 | 13 | 0 | 1 | 0.3 (0.0-0.6) | 1.3 (0.6-2.0) | 1.7 (0.9-2.5) | 1.8 (1.0-2.7) | 2.7 (1.4-4.0) | n.a. | ||||
Twinsys stem Cemented | CCB cup Low Profile | 884 | 80 (77-83) | 11 | 1 | 3 | 6 | 0 | 1 | 0.5 (0.0-1.0) | 1.1 (0.3-1.8) | 1.5 (0.5-2.5) | 1.8 (0.7-3.0) | 1.8 (0.7-3.0) | n.a. | ||||
Stanmore | Muller | 877* | 76 (71-81) | 12 | 3 | 2 | 6 | 1 | 0 | 0.7 (0.1-1.2) | 1.3 (0.5-2.0) | 1.3 (0.5-2.0) | 1.3 (0.5-2.0) | 1.7 (0.6-2.8) | n.a. | ||||
Spectron EF | Mueller cup | 831* | 77 (72-81) | 12 | 3 | 2 | 4 | 3 | 0 | 0.4 (0.0-0.8) | 0.7 (0.1-1.3) | 1.0 (0.3-1.6) | 1.1 (0.4-1.8) | 1.4 (0.6-2.2) | 1.6 (0.7-2.5) | ||||
Lubinus SPII | AVANTAGE Cemented | 731 | 78 (72-83) | 24 | 5 | 0 | 2 | 17 | 0 | 2.7 (1.5-3.9) | 2.9 (1.6-4.1) | 4.1 (2.2-6.0) | 5.0 (2.5-7.6) | n.a. | n.a. | ||||
Spectron EF | Reflection All Poly | 617* | 77 (74-82) | 47 | 11 | 0 | 32 | 4 | 0 | 0.8 (0.1-1.5) | 1.8 (0.7-2.9) | 2.7 (1.4-4.0) | 3.3 (1.8-4.7) | 6.6 (4.5-8.8) | 10.2 (7.2-13.2) | ||||
Spectron EF | Muller low profile Durasul | 503* | 78 (74-83) | 12 | 4 | 0 | 2 | 6 | 0 | 0.8 (0.0-1.6) | 1.7 (0.5-2.8) | 2.3 (0.8-3.7) | n.a. | n.a. | n.a. | ||||
MS30 | Muller low profile | 497* | 78 (74-82) | 16 | 0 | 8 | 8 | 0 | 0 | 0.8 (0.0-1.6) | 1.7 (0.5-2.8) | 2.4 (1.0-3.7) | 3.0 (1.4-4.6) | 4.5 (2.1-6.9) | n.a. | ||||
Stanmore | Apollo | 381* | 75 (70-79) | 6 | 3 | 1 | 1 | 0 | 1 | 0.3 (0.0-0.8) | 0.8 (0.0-1.7) | 1.4 (0.2-2.6) | 1.4 (0.2-2.6) | 1.8 (0.4-3.2) | n.a. | ||||
Stanmore | Avantage Cemented | 368 | 79 (74-84) | 10 | 0 | 1 | 0 | 9 | 0 | 2.2 (0.7-3.7) | 2.7 (1.1-4.4) | 2.7 (1.1-4.4) | n.a. | n.a. | n.a. | ||||
Exeter | Avantage Cemented | 353 | 74 (65-82) | 8 | 3 | 2 | 0 | 3 | 0 | 1.5 (0.2-2.9) | 2.5 (0.6-4.4) | 3.1 (0.9-5.4) | 3.1 (0.9-5.4) | n.a. | n.a. | ||||
Lubinus SPII | FAL Cup X-Linked | 304 | 78 (74-81) | 3 | 0 | 0 | 2 | 1 | 0 | 0.7 (0.0-1.8) | 0.7 (0.0-1.8) | n.a. | n.a. | n.a. | n.a. | ||||
GHE-huftstiel | Huftpfanne | 273* | 75 (71-80) | 23 | 5 | 3 | 15 | 0 | 0 | 0.4 (0.0-1.1) | 1.5 (0.0-3.0) | 2.7 (0.7-4.7) | 4.4 (1.8-6.9) | 7.2 (3.9-10.6) | n.a. | ||||
Charnley Modular | Marathon | 255* | 71 (65-79) | 10 | 3 | 5 | 2 | 0 | 0 | 0.4 (0.0-1.2) | 1.2 (0.0-2.6) | 1.6 (0.0-3.2) | 4.0 (1.4-6.5) | 4.5 (1.8-7.3) | n.a. |
* Denotes prosthesis combinations with no reported use in primary THAs in 2021.
Please note: n.a. if <50 cases were at risk; THA: total hip arthroplasty; CI: confidence interval; IQR: interquartile range.
© LROI 2022
Only combinations with over 250 procedures have been listed.
Results must be interpreted with caution. Patient characteristics like age and diagnosis, as well as procedure characteristics like the experience of the surgeon performing the procedure, femoral head size and articulation of the prosthesis may have influenced the cumulative revision percentages.
Hip » Survival » Revision per component » Uncemented primary THA – overall revision
TABLE Cumulative revision percentages of uncemented primary total hip arthroplasties by prosthesis component combination of patients who underwent a THA for osteoarthritis in the Netherlands in 2007-2021 (n=212,796)
Type of revision (n) | Cumulative revision percentage (95% CI) | ||||||||||||||
Femur component | Acetabulum component | Total primary THAs (n) | Median (IQR) age (yr) | Total RAs (n) | Total hip (complete revision) | Only femur component | Only acetabulum component | Only femoral head/inlay | Missing/ unknown | 1yr | 3yr | 5yr | 7yr | 10yr | 13yr |
All uncemented THAs for osteoarthritis | 212,796 | 68 (62-74) | 7,307 | 1,198 | 2,568 | 1,909 | 1,511 | 121 | 1.5 (1.5-1.6) | 2.5 (2.4-2.6) | 3.2 (3.1-3.3) | 3.8 (3.7-3.9) | 4.7 (4.6-4.8) | 5.7 (5.5-5.9) | |
Corail | Pinnacle | 37,203 | 69 (63-75) | 842 | 154 | 256 | 178 | 244 | 10 | 1.2 (1.0-1.3) | 1.8 (1.7-2.0) | 2.3 (2.1-2.5) | 2.6 (2.4-2.8) | 3.4 (3.1-3.7) | 3.9 (3.4-4.4) |
Taperloc Complete | Allofit | 19,329 | 67 (61-73) | 349 | 62 | 125 | 66 | 93 | 3 | 1.4 (1.2-1.6) | 2.0 (1.8-2.2) | 2.3 (2.0-2.6) | 2.5 (2.0-2.9) | n.a. | n.a. |
Alloclassic Zweymuller SL | Allofit | 14,468 | 70 (64-76) | 498 | 76 | 193 | 121 | 102 | 6 | 1.2 (1.0-1.3) | 2.0 (1.8-2.2) | 2.6 (2.4-2.9) | 3.2 (2.8-3.5) | 4.3 (3.9-4.7) | 4.9 (4.4-5.4) |
CLS Spotorno | Allofit | 11,068 | 64 (58-69) | 486 | 52 | 190 | 130 | 96 | 18 | 2.6 (2.3-2.9) | 3.6 (3.2-3.9) | 4.1 (3.7-4.4) | 4.6 (4.2-5.0) | 5.2 (4.7-5.7) | 5.7 (5.0-6.3) |
Polarstem | R3 | 10,103 | 69 (63-75) | 211 | 20 | 72 | 24 | 94 | 1 | 1.8 (1.6-2.1) | 2.4 (2.0-2.7) | 2.7 (2.2-3.2) | n.a. | n.a. | n.a. |
Taperloc Complete | Exceed ABT | 8,663 | 69 (63-75) | 192 | 34 | 70 | 35 | 49 | 4 | 1.4 (1.2-1.7) | 1.9 (1.6-2.2) | 2.3 (1.9-2.6) | 2.6 (2.2-3.0) | 2.8 (2.3-3.2) | n.a. |
Accolade | Trident | 7,605 | 69 (62-76) | 311 | 44 | 161 | 44 | 60 | 2 | 1.4 (1.1-1.7) | 2.8 (2.4-3.2) | 3.7 (3.3-4.2) | 4.4 (3.9-4.9) | 5.3 (4.6-6.0) | 7.6 (6.0-9.1) |
Mallory Head Stems | Mallory Head | 6,018 | 65 (60-69) | 214 | 27 | 23 | 91 | 67 | 6 | 1.4 (1.1-1.7) | 2.3 (1.9-2.6) | 2.7 (2.3-3.1) | 3.2 (2.7-3.7) | 3.7 (3.2-4.2) | 4.6 (3.9-5.4) |
Accolade | Trident Tritanium | 4,539* | 68 (62-74) | 120 | 11 | 44 | 22 | 42 | 1 | 1.1 (0.8-1.4) | 2.2 (1.7-2.6) | 2.7 (2.2-3.2) | 3.1 (2.5-3.6) | n.a. | n.a. |
Twinsys stem Cementless | RM Pressfit Vitamys cup | 4,299 | 66 (60-71) | 118 | 15 | 55 | 28 | 18 | 2 | 1.7 (1.3-2.1) | 2.3 (1.8-2.7) | 2.7 (2.2-3.2) | 3.0 (2.4-3.7) | 4.9 (3.7-6.2) | n.a. |
Taperloc HIP system | Exceed ABT | 3,892* | 68 (62-75) | 121 | 20 | 32 | 36 | 25 | 8 | 1.2 (0.8-1.5) | 2.3 (1.8-2.8) | 2.7 (2.2-3.2) | 2.9 (2.4-3.5) | 3.3 (2.7-3.9) | n.a. |
SL Plus | Bicon Plus | 3,777 | 70 (64-76) | 260 | 38 | 131 | 72 | 16 | 3 | 1.7 (1.3-2.1) | 3.9 (3.3-4.6) | 5.4 (4.6-6.1) | 6.3 (5.5-7.1) | 7.7 (6.7-8.6) | 8.7 (7.5-9.9) |
Taperloc HIP system | Mallory Head | 3,670* | 67 (61-71) | 135 | 26 | 38 | 48 | 22 | 1 | 1.5 (1.1-1.8) | 2.6 (2.1-3.1) | 2.9 (2.4-3.5) | 3.5 (2.8-4.1) | 3.8 (3.1-4.4) | 4.9 (3.9-6.0) |
Accolade II | Trident | 3,503 | 70 (63-75) | 60 | 10 | 21 | 9 | 19 | 1 | 1.8 (1.3-2.2) | 2.4 (1.5-3.4) | 2.4 (1.5-3.4) | n.a. | n.a. | n.a. |
Twinsys stem Cementless | RM Pressfit cup | 3,285 | 73 (68-78) | 121 | 16 | 55 | 23 | 26 | 1 | 2.5 (2.0-3.1) | 3.2 (2.5-3.8) | 3.5 (2.8-4.1) | 4.0 (3.2-4.7) | 4.6 (3.6-5.5) | n.a. |
Taperloc Complete | Mallory Head | 3,105 | 67 (61-72) | 114 | 20 | 25 | 30 | 38 | 1 | 2.1 (1.6-2.6) | 3.1 (2.5-3.7) | 3.4 (2.7-4.0) | 3.8 (3.1-4.5) | 5.0 (3.5-6.5) | n.a. |
Synergy | Reflection | 2,930* | 66 (60-72) | 139 | 11 | 67 | 29 | 31 | 1 | 2.1 (1.6-2.6) | 2.7 (2.1-3.3) | 3.1 (2.5-3.7) | 3.6 (2.9-4.3) | 4.5 (3.7-5.3) | 6.2 (5.1-7.3) |
Alloclassic Zweymuller SL | Alloclassic Zweymuller CSF | 2,903* | 69 (63-75) | 127 | 16 | 50 | 24 | 35 | 2 | 1.1 (0.7-1.5) | 2.7 (2.1-3.2) | 3.3 (2.6-3.9) | 3.5 (2.9-4.2) | 4.4 (3.6-5.2) | 4.9 (4.0-5.8) |
Alloclassic offset | Allofit | 2,770 | 71 (65-77) | 80 | 16 | 32 | 15 | 14 | 3 | 1.3 (0.9-1.7) | 2.0 (1.4-2.5) | 2.6 (1.9-3.2) | 2.9 (2.2-3.6) | 3.6 (2.8-4.5) | 4.1 (3.1-5.2) |
M/L Taper | Allofit IT | 2,144 | 71 (65-76) | 74 | 10 | 29 | 24 | 10 | 1 | 2.3 (1.6-2.9) | 3.2 (2.4-4.0) | 3.7 (2.8-4.5) | 4.0 (3.1-5.0) | 4.3 (3.2-5.3) | n.a. |
Synergy | R3 | 2,096 | 66 (60-72) | 62 | 10 | 34 | 8 | 8 | 2 | 1.8 (1.2-2.4) | 2.3 (1.7-3.0) | 2.8 (2.1-3.5) | 3.1 (2.3-3.9) | 3.2 (2.4-4.0) | n.a. |
SYMAX | Trident | 2,073* | 69 (63-75) | 71 | 6 | 18 | 20 | 27 | 0 | 0.6 (0.3-0.9) | 1.7 (1.1-2.2) | 2.2 (1.5-2.8) | 2.8 (2.0-3.5) | 3.2 (2.5-4.0) | 4.0 (3.1-5.0) |
Anthology | R3 | 1,841 | 65 (59-69) | 59 | 8 | 20 | 16 | 15 | 0 | 2.1 (1.4-2.7) | 2.6 (1.9-3.3) | 3.4 (2.5-4.2) | 3.6 (2.7-4.5) | 3.6 (2.7-4.5) | n.a. |
SYMAX | Trident Tritanium | 1,743* | 67 (61-73) | 85 | 10 | 37 | 24 | 13 | 1 | 2.3 (1.6-3.0) | 3.6 (2.7-4.5) | 4.0 (3.0-4.9) | 4.6 (3.6-5.6) | 5.4 (4.2-6.6) | n.a. |
Corail AMT | Pinnacle | 1,683 | 69 (62-74) | 16 | 2 | 5 | 4 | 5 | 0 | 0.7 (0.3-1.1) | 1.2 (0.5-1.8) | n.a. | n.a. | n.a. | n.a. |
* Denotes prosthesis combinations with no reported use in primary THAs in 2021.
Please note: n.a. if <50 cases were at risk; THA: total hip arthroplasty; CI: confidence interval; IQR: interquartile range.
© LROI 2022
TABLE Continued – Cumulative revision percentages of uncemented primary total hip arthroplasties by prosthesis component combination of patients who underwent a THA for osteoarthritis in the Netherlands in 2007-2021 (n=212,796)
Type of revision (n) | Cumulative revision percentage (95% CI) | ||||||||||||||
Femur component | Acetabulum component | Total primary THAs (n) | Median (IQR) age (yr) | Total RAs (n) | Total hip (complete revision) | Only femur component | Only acetabulum component | Only femoral head/inlay | Missing/ unknown | 1yr | 3yr | 5yr | 7yr | 10yr | 13yr |
Mallory Head Stems | Exceed ABT | 1,637* | 65 (59-71) | 36 | 3 | 15 | 16 | 2 | 0 | 0.7 (0.3-1.1) | 1.6 (1.0-2.2) | 1.7 (1.0-2.3) | 2.0 (1.3-2.7) | 2.4 (1.6-3.2) | n.a. |
OMNIFIT HA | Trident | 1,501* | 63 (57-67) | 145 | 18 | 70 | 24 | 29 | 4 | 3.1 (2.2-3.9) | 4.5 (3.4-5.5) | 6.3 (5.0-7.5) | 7.8 (6.4-9.1) | 9.5 (8.0-11.0) | 10.5 (8.8-12.2) |
M/L Taper | Continuum | 1,265 | 68 (63-73) | 22 | 2 | 17 | 2 | 1 | 0 | 1.5 (0.8-2.2) | 1.9 (1.1-2.7) | 1.9 (1.1-2.7) | n.a. | n.a. | n.a. |
Alloclassic Zweymuller SL | Continuum | 1,207 | 71 (64-77) | 31 | 7 | 12 | 4 | 7 | 1 | 1.3 (0.7-2.0) | 2.0 (1.2-2.8) | 2.4 (1.5-3.3) | 2.6 (1.7-3.6) | n.a. | n.a. |
Taperloc Complete | G7 PPS | 1,199 | 69 (63-75) | 22 | 6 | 9 | 4 | 3 | 0 | 2.3 (1.3-3.3) | n.a. | n.a. | n.a. | n.a. | n.a. |
Fitmore | Allofit | 1,187 | 67 (62-72) | 13 | 3 | 3 | 1 | 6 | 0 | 1.0 (0.4-1.6) | n.a. | n.a. | n.a. | n.a. | n.a. |
CLS Spotorno | RM Classic cup | 1,178* | 63 (58-68) | 75 | 14 | 21 | 32 | 7 | 1 | 1.9 (1.1-2.6) | 2.6 (1.7-3.6) | 3.3 (2.3-4.4) | 3.9 (2.8-5.0) | 5.1 (3.8-6.4) | 6.6 (5.1-8.1) |
CLS Spotorno | Pinnacle | 1,166* | 67 (62-72) | 50 | 7 | 17 | 10 | 16 | 0 | 1.3 (0.6-1.9) | 2.3 (1.4-3.1) | 2.8 (1.9-3.8) | 3.6 (2.5-4.8) | 5.2 (3.7-6.7) | n.a. |
SL Plus Mia | R3 | 1,109* | 71 (65-77) | 33 | 3 | 16 | 6 | 8 | 0 | 1.9 (1.1-2.7) | 2.7 (1.8-3.7) | 3.1 (2.0-4.1) | 3.1 (2.0-4.1) | 3.1 (2.0-4.1) | n.a. |
SL Plus | Reflection | 1,020* | 67 (61-73) | 42 | 5 | 14 | 14 | 9 | 0 | 1.8 (1.0-2.6) | 3.3 (2.2-4.4) | 3.8 (2.6-5.0) | 4.4 (3.1-5.7) | 4.4 (3.1-5.7) | n.a. |
Avenir Muller | Allofit | 1,006 | 69 (62-73) | 16 | 2 | 7 | 2 | 5 | 0 | 1.3 (0.6-2.0) | 1.4 (0.6-2.2) | 1.7 (0.8-2.6) | 2.2 (1.0-3.4) | 2.2 (1.0-3.4) | n.a. |
SL Plus | Hofer-Imhoff Lubrimet | 977* | 70 (64-76) | 57 | 13 | 27 | 9 | 6 | 2 | 1.1 (0.5-1.8) | 2.3 (1.3-3.2) | 3.6 (2.4-4.7) | 4.5 (3.1-5.8) | 5.6 (4.1-7.1) | 6.7 (4.8-8.5) |
Alloclassic Zweymuller SL | Trilogy | 968* | 68 (63-75) | 35 | 10 | 10 | 7 | 8 | 0 | 1.3 (0.6-2.1) | 2.2 (1.3-3.1) | 2.6 (1.6-3.6) | 2.9 (1.9-4.0) | 3.6 (2.4-4.8) | 3.7 (2.5-5.0) |
Polarstem | Reflection | 927* | 70 (64-76) | 18 | 5 | 4 | 2 | 7 | 0 | 1.1 (0.4-1.7) | 1.6 (0.8-2.4) | 2.2 (1.2-3.3) | 2.2 (1.2-3.3) | n.a. | n.a. |
Summit Tapered | Pinnacle Gription | 880 | 68 (62-73) | 19 | 2 | 5 | 2 | 9 | 1 | 1.9 (1.0-2.8) | 2.2 (1.2-3.2) | 2.6 (1.3-3.8) | n.a. | n.a. | n.a. |
SL Plus | EP-Fit Plus | 790* | 68 (63-75) | 45 | 10 | 24 | 10 | 1 | 0 | 1.3 (0.5-2.1) | 3.1 (1.9-4.3) | 3.8 (2.4-5.1) | 4.9 (3.3-6.4) | 5.7 (4.0-7.4) | 6.5 (4.6-8.3) |
Alloclassic Zweymuller SL | Alloclassic Variall | 778* | 71 (64-77) | 23 | 4 | 10 | 3 | 5 | 1 | 1.0 (0.3-1.7) | 1.9 (1.0-2.9) | 2.4 (1.3-3.4) | 2.6 (1.5-3.8) | 3.0 (1.7-4.2) | 3.5 (1.9-5.1) |
CLS Spotorno | Fitmore | 758* | 66 (61-71) | 36 | 3 | 16 | 6 | 10 | 1 | 1.9 (0.9-2.8) | 2.4 (1.3-3.5) | 2.6 (1.5-3.8) | 3.3 (2.0-4.6) | 4.4 (2.9-5.9) | 5.2 (3.5-6.9) |
DB10 | Spidercup | 755* | 71 (64-77) | 39 | 2 | 19 | 10 | 7 | 1 | 1.5 (0.6-2.3) | 2.3 (1.2-3.3) | 2.9 (1.6-4.1) | 3.7 (2.4-5.1) | 5.0 (3.3-6.7) | 7.2 (4.6-9.7) |
Taperloc Complete | Continuum | 751 | 68 (59-74) | 15 | 4 | 5 | 1 | 5 | 0 | 1.9 (0.9-2.9) | 2.7 (0.9-4.4) | n.a. | n.a. | n.a. | n.a. |
CLS Spotorno | Morscher | 712* | 73 (68-78) | 37 | 6 | 19 | 12 | 0 | 0 | 1.3 (0.4-2.1) | 2.6 (1.4-3.7) | 3.2 (1.9-4.5) | 4.2 (2.7-5.7) | 5.9 (3.9-7.8) | 7.8 (4.5-11.1) |
Optimys stem | RM Pressfit Vitamys cup | 677 | 62 (55-68) | 14 | 2 | 9 | 2 | 1 | 0 | 2.0 (0.9-3.1) | 2.4 (1.1-3.7) | 2.4 (1.1-3.7) | n.a. | n.a. | n.a. |
CLS Spotorno | RM Pressfit cup | 625* | 66 (60-71) | 52 | 5 | 21 | 18 | 5 | 3 | 3.1 (1.7-4.4) | 4.4 (2.8-6.0) | 5.7 (3.9-7.6) | 6.5 (4.5-8.5) | 7.8 (5.6-10.0) | 9.8 (7.2-12.4) |
CBH stem | RM Pressfit Vitamys cup | 593* | 65 (60-70) | 24 | 8 | 7 | 7 | 2 | 0 | 1.0 (0.2-1.8) | 2.4 (1.1-3.6) | 3.3 (1.8-4.7) | 4.0 (2.4-5.6) | n.a. | n.a. |
CBH stem | RM Pressfit cup | 551* | 75 (69-79) | 23 | 4 | 6 | 11 | 2 | 0 | 2.2 (1.0-3.4) | 3.7 (2.1-5.3) | 3.9 (2.3-5.5) | 4.3 (2.6-6.1) | n.a. | n.a. |
Alloclassic Zweymuller SL | Trabecular Metal | 547* | 68 (62-75) | 25 | 2 | 7 | 9 | 6 | 1 | 0.6 (0.0-1.2) | 1.9 (0.7-3.0) | 2.6 (1.3-4.0) | 3.2 (1.7-4.7) | 3.4 (1.8-4.9) | 4.8 (2.8-6.8) |
* Denotes prosthesis combinations with no reported use in primary THAs in 2021.
Please note: n.a. if <50 cases were at risk; THA: total hip arthroplasty; CI: confidence interval; IQR: interquartile range.
© LROI 2022
Only combinations with over 500 procedures have been listed.
Results must be interpreted with caution. Patient characteristics like age and diagnosis, as well as procedure characteristics like the experience of the surgeon performing the procedure, femoral head size and articulation of the prosthesis may have influenced the cumulative revision percentages.
Hip » Survival » Revision per component » Cemented primary THA – major revision
TABLE Cumulative major revision percentages of the most frequently used cemented primary total hip arthroplasties by prosthesis component combination of patients who underwent a THA for osteoarthritis in the Netherlands in 2007-2021 (n=82,092)
Cumulative revision percentage Kaplan Meier (95% CI) | ||||||||||
Femur component | Acetabulum component | Total primary THAs (n) | Median (IQR) age (yr) | Major revision¹ arthroplasties (n) | 1yr | 3yr | 5yr | 7yr | 10yr | 13yr |
All cemented THAs for osteoarthritis | 82,092 | 76 (71-81) | 1,755 | 0.7 (0.6-0.7) | 1.4 (1.3-1.4) | 1.8 (1.7-1.9) | 2.3 (2.2-2.4) | 3.0 (2.8-3.1) | 3.8 (3.6-4.1) | |
Lubinus SPII | IP Cup | 14,118 | 76 (72-81) | 287 | 0.6 (0.4-0.7) | 1.4 (1.2-1.6) | 1.9 (1.7-2.2) | 2.2 (1.9-2.5) | 2.7 (2.3-3.0) | 3.7 (3.0-4.3) |
Original ME Muller | Muller low profile Durasul | 8,498 | 75 (70-80) | 94 | 0.5 (0.4-0.7) | 0.9 (0.6-1.1 | 1.2 (0.9-1.5) | 1.4 (1.1-1.7) | 1.8 (1.4-2.2) | 1.8 (1.4-2.2) |
Original ME Muller | Muller low profile | 6,324 | 77 (73-81) | 136 | 0.9 (0.7-1.1) | 1.8 (1.4-2.1) | 2.1 (1.7-2.4) | 2.4 (2.0-2.8) | 2.4 (2.0-2.8) | 2.7 (2.1-3.2) |
Lubinus SPII | FAL Cup | 5,760 | 75 (70-80) | 133 | 1.0 (0.7-1.2) | 1.6 (1.3-2.0) | 2.3 (1.8-2.7) | 2.9 (2.4-3.5) | 3.6 (2.9-4.3) | 4.0 (3.1-5.0) |
Spectron EF | Reflection All Poly XLPE | 4,878 | 77 (73-81) | 92 | 0.4 (0.2-0.5) | 1.1 (0.8-1.3) | 1.5 (1.1-1.8) | 2.1 (1.7-2.6) | 2.4 (1.9-2.9) | 2.6 (2.0-3.1) |
Exeter | Exeter Rimfit X3 | 4,664 | 75 (69-80) | 66 | 0.7 (0.5-0.9) | 1.2 (0.9-1.6) | 1.7 (1.3-2.1) | 1.7 (1.3-2.1) | 1.8 (1.3-2.3) | n.a. |
Stanmore | Stanmore | 3,374 | 75 (70-80) | 67 | 0.5 (0.3-0.8) | 1.3 (0.9-1.7) | 1.7 (1.2-2.1) | 1.9 (1.4-2.3) | 2.3 (1.7-2.9) | 2.5 (1.8-3.2) |
Exeter | Exeter Contemporary Hooded | 2,827* | 77 (72-81) | 81 | 0.7 (0.4-1.0) | 1.2 (0.8-1.6) | 1.8 (1.3-2.3) | 2.3 (1.7-2.9) | 3.8 (2.9-4.7) | 4.3 (3.2-5.3) |
Lubinus SPII | SHP | 2,506* | 75 (71-80) | 44 | 0.2 (0.0-0.4) | 0.6 (0.3-0.9) | 0.9 (0.5-1.3) | 1.7 (1.1-2.2) | 1.9 (1.4-2.5) | 2.0 (1.4-2.6) |
Exeter | Exeter | 2,447* | 73 (68-79) | 115 | 1.8 (1.2-2.3) | 2.5 (1.9-3.1) | 3.1 (2.4-3.8) | 3.8 (3.0-4.6) | 5.1 (4.1-6.1) | 5.8 (4.7-6.9) |
¹ Revision of at least the acetabulum or femur component.
* Denotes prosthesis combinations with no reported use in primary THAs in 2021.
Please note: n.a. if <50 cases were at risk; THA: total hip arthroplasty; CI: confidence interval; IQR: interquartile range.
© LROI 2022
Results must be interpreted with caution. Patient characteristics like age and diagnosis, as well as procedure characteristics like the experience of the surgeon performing the procedure, femoral head size and articulation of the prosthesis may have influenced the cumulative revision percentages.
Hip » Survival » Revision per component » Uncemented primary THA – major revision
TABLE Cumulative major revision percentages of the most frequently used uncemented primary total hip arthroplasties by prosthesis component combination of patients who underwent a THA for osteoarthritis in the Netherlands in 2007-2021 (n=212,796)
Cumulative revision percentage (95% CI) | ||||||||||
Femur component | Acetabulum component | Total primary THAs (n) | Median (IQR) age (yr) | Major revision¹ arthroplasties (n) | 1yr | 3yr | 5yr | 7yr | 10yr | 13 yr |
All uncemented THAs for osteoarthritis | 212,796 | 68 (62-74) | 5,936 | 1.1 (1.1-1.1) | 2.0 (1.9-2.0) | 2.6 (2.5-2.6) | 3.1 (3.0-3.2) | 3.9 (3.8-4.0) | 4.9 (4.7-5.0) | |
Corail | Pinnacle | 37,202 | 69 (63-75) | 632 | 0.7 (0.7-0.8) | 1.3 (1.3-1.4) | 1.8 (1.8-1.9) | 2.0 (2.0-2.2) | 2.7 (2.7-2.9) | 3.1 (3.1-3.6) |
Taperloc Complete | Allofit | 19,329 | 67 (61-73) | 267 | 1.0 (1.0-1.2) | 1.6 (1.6-1.8) | 1.9 (1.9-2.1) | 2.0 (2.0-2.4) | 2.0 (2.0-2.4) | 2.0 (2.0-2.4) |
Alloclassic Zweymuller SL | Allofit | 14,468 | 70 (64-76) | 405 | 0.9 (0.9-1.0) | 1.6 (1.6-1.8) | 2.1 (2.1-2.4) | 2.5 (2.5-2.8) | 3.5 (3.5-3.8) | 4.1 (4.1-4.6) |
CLS Spotorno | Allofit | 11,068 | 64 (58-69) | 395 | 1.9 (1.9-2.1) | 2.8 (2.8-3.1) | 3.2 (3.2-3.6) | 3.8 (3.8-4.1) | 4.4 (4.4-4.9) | 4.8 (4.8-5.5) |
Polarstem | R3 | 10,103 | 69 (63-75) | 125 | 1.0 (1.0-1.2) | 1.5 (1.5-1.7) | 1.8 (1.8-2.3) | n.a. | n.a. | n.a. |
Taperloc Complete | Exceed ABT | 8,663 | 69 (63-75) | 147 | 1.1 (1.1-1.3) | 1.5 (1.5-1.7) | 1.7 (1.7-2.0) | 2.0 (2.0-2.4) | 2.2 (2.2-2.6) | n.a. |
Accolade | Trident | 7,605 | 69 (62-76) | 260 | 1.0 (1.0-1.3) | 2.2 (2.2-2.6) | 3.1 (3.1-3.5) | 3.6 (3.6-4.1) | 4.6 (4.6-5.2) | 7.0 (7.0-8.6) |
Mallory Head Stems | Mallory Head | 6,018 | 65 (60-69) | 156 | 0.9 (0.9-1.2) | 1.6 (1.6-1.9) | 2.0 (2.0-2.4) | 2.4 (2.4-2.8) | 2.8 (2.8-3.2) | 3.3 (3.3-4.0) |
Accolade | Trident Tritanium | 4,539* | 68 (62-74) | 78 | 0.6 (0.6-0.8) | 1.4 (1.4-1.8) | 1.8 (1.8-2.2) | 2.0 (2.0-2.5) | n.a. | n.a. |
Twinsys stem Cementless | RM Pressfit Vitamys cup | 4,299 | 66 (60-71) | 102 | 1.4 (1.4-1.7) | 1.9 (1.9-2.3) | 2.3 (2.3-2.8) | 2.7 (2.7-3.3) | 4.4 (4.4-5.6) | n.a. |
¹ Revision of at least the acetabulum or femur component.
Please note: n.a. if <50 cases were at risk; THA: total hip arthroplasty; CI: confidence interval; IQR: interquartile range.
© LROI 2022
Results must be interpreted with caution. Patient characteristics like age and diagnosis, as well as procedure characteristics like the experience of the surgeon performing the procedure, femoral head size and articulation of the prosthesis may have influenced the cumulative revision percentages.
Hip » Survival » Revision per component » Bone cement THA
TABLE Cumulative revision percentages of the most frequently types of bone cement by type of mixing system in primary total hip arthroplasties in the Netherlands in 2007-2021
Cumulative revision percentage Kaplan Meier (95% CI) | ||||||||
Bone cement | Total primary THAs (n) | Total RAs (n) | 1yr | 3yr | 5yr | 7yr | 10yr | 13yr |
Separately packed bone cement components | 90,412 | 3,081 | 1.4 (1.4-1.5) | 2.4 (2.3-2.5) | 3.0 (2.9-3.1) | 3.5 (3.4-3.6) | 4.3 (4.2-4.5) | 5.3 (5.0-5.6) |
Palacos R+G | 69,263 | 2,283 | 1.5 (1.4-1.6) | 2.5 (2.3-2.6) | 3.0 (2.9-3.2) | 3.5 (3.3-3.6) | 4.2 (4.0-4.4) | 5.2 (4.8-5.5) |
Refobacin Bone Cement R | 6,178 | 182 | 1.0 (0.8-1.3) | 1.9 (1.6-2.3) | 2.3 (1.9-2.7) | 2.8 (2.4-3.3) | 3.7 (3.1-4.2) | 3.8 (3.2-4.4) |
Palacos MV+G | 3,720 | 93 | 0.9 (0.6-1.2) | 1.4 (1.0-1.8) | 2.1 (1.6-2.6) | 3.1 (2.5-3.8) | 3.5 (2.8-4.3) | n.a. |
Simplex ABC EC | 2,670 | 146 | 2.2 (1.6-2.7) | 3.5 (2.8-4.2) | 4.4 (3.6-5.2) | 5.1 (4.2-6.0) | 6.7 (5.5-7.9) | 9.0 (6.8-11.3) |
Simplex ABC Tobra | 2,304 | 143 | 2.0 (1.4-2.6) | 3.3 (2.5-4.0) | 4.0 (3.2-4.8) | 4.7 (3.8-5.6) | 6.5 (5.4-7.6) | 7.6 (6.3-8.9) |
Simplex P | 1,321* | 29 | 0.8 (0.3-1.2) | 1.8 (1.1-2.5) | 1.9 (1.1-2.6) | 2.1 (1.3-2.9) | 2.7 (1.7-3.8) | 2.7 (1.7-3.8) |
Simplex HV | 572* | 12 | 0.7 (0.0-1.4) | 0.9 (0.1-1.7) | 2.1 (0.9-3.3) | 2.6 (1.0-4.2) | n.a. | n.a. |
Refobacin Plus Bone Cement | 557* | 22 | 1.6 (0.6-2.7) | 2.6 (1.2-3.9) | 3.4 (1.8-4.9) | 3.7 (2.0-5.3) | 4.3 (2.5-6.2) | 4.8 (2.7-6.9) |
Palamed G | 493* | 14 | 0.4 (0.0-1.0) | 0.8 (0.0-1.6) | 1.3 (0.3-2.3) | 2.0 (0.7-3.2) | 3.0 (1.4-4.6) | 3.3 (1.6-4.9) |
Biomet Plus Bone Cement | 453* | 26 | 0.4 (0.0-1.1) | 1.4 (0.3-2.4) | 2.5 (1.1-4.0) | 3.3 (1.6-5.0) | 4.4 (2.4-6.3) | 7.4 (4.5-10.3) |
Subiton G | 381 | 6 | 0.9 (0.0-2.0) | 2.5 (0.4-4.5) | n.a. | n.a. | n.a. | n.a. |
CMW 1 Gentamicin Bone Cement | 326* | 13 | 1.9 (0.4-3.3) | 2.8 (1.0-4.6) | 3.1 (1.2-5.0) | 3.1 (1.2-5.0) | 4.0 (1.7-6.2) | 4.5 (2.1-6.8) |
Palacos R | 312 | 16 | 1.6 (0.2-3.0) | 2.7 (0.8-4.5) | 4.2 (1.9-6.5) | 5.0 (2.4-7.6) | 6.2 (3.2-9.3) | n.a. |
Palamed | 277* | 22 | 1.1 (0.0-2.3) | 2.5 (0.7-4.4) | 3.7 (1.4-5.9) | 3.7 (1.4-5.9) | 6.1 (3.2-9.0) | 8.9 (5.3-12.4) |
Bone cement pre-packed in a vacuum mixing system | 31,948 | 902 | 1.9 (1.8-2.1) | 2.7 (2.5-2.9) | 3.3 (3.0-3.5) | 3.8 (3.5-4.1) | 4.6 (4.1-5.2) | 5.1 (4.3-5.8) |
Refobacin Bone Cement R | 15,726 | 469 | 2.0 (1.8-2.2) | 2.8 (2.5-3.0) | 3.3 (3.0-3.7) | 3.9 (3.5-4.3) | 5.2 (4.2-6.1) | n.a. |
Palacos R+G | 11,237 | 297 | 2.1 (1.8-2.3) | 2.9 (2.5-3.2) | 3.6 (3.1-4.0) | n.a. | n.a. | n.a. |
Refobacin Plus Bone Cement | 4,296 | 114 | 1.3 (0.9-1.6) | 2.1 (1.7-2.6) | 2.6 (2.1-3.1) | 3.1 (2.5-3.7) | 3.4 (2.7-4.1) | n.a. |
Cemex Genta | 429 | 10 | 1.2 (0.2-2.2) | 1.9 (0.6-3.2) | 2.2 (0.8-3.6) | 2.2 (0.8-3.6) | 3.8 (0.4-7.2) | n.a. |
* Denotes types of bone cement with no reported use in primary THAs in 2021.
Please note: n.a. if <50 cases were at risk; THA: total hip arthroplasty; CI: confidence interval; IQR: interquartile range.
© LROI 2022
Only types of bone cement with over 250 procedures have been listed.
Results must be interpreted with caution. Patient characteristics like age and diagnosis, as well as procedure characteristics like the experience of the surgeon performing the procedure, femoral head size and articulation of the prosthesis may have influenced the cumulative revision percentages.
Hip » Survival » Revision per component » THA by ODEP 5A or higher acetabulum
ODEP rating
Orthopaedic Data Evaluation Panel. ODEP provides ratings for hip femoral stems, hip acetabular cups and total knee replacement implants. An ODEP rating consists of a number and a letter (A or B), and a star (optional). The number represents the number of years for which the product’s performance had been evidenced. The letter represents the strength of evidence presented by the manufacturer (A represents strong evidence and B represents acceptable evidence). A Star (*) represents very strong evidence above A and B. Detailed information can be found at www.odep.org.uk
FIGURE Cumulative acetabulum revision percentage of total hip arthroplasties by ODEP rating acetabulum in the Netherlands in 2007-2021 (n= 376,606)
TABLE Cumulative 13-year acetabulum revision percentage
Cumulative 13-year acetabulum revision percentage | |||
Number (n) | Competing Risk1 (95% CI) | Kaplan Meier (95% CI) | |
ODEP acetabulum | |||
<5A | 20,452 | 5.9 (5.5-6.3) | 7.0 (6.5-7.4) |
5A or higher | 356,154 | 2.4 (2.3-2.5) | 3.0 (2.9-3.1) |
¹ The cumulative revision percentage using the competing risk method is shown in the figure.
Acetabulum revision percentage: first revision of the acetabulum component, regardless of whether a minor revision has already taken place. Therefor, the first three revision procedures were reviewed.
ODEP rating: ODEP provides ratings for hip femoral stems, hip acetabular cups and total knee replacement implants. Detailed information can be found at www.odep.org.uk.
Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
THA: total hip arthroplasty; CI: confidence interval.
© LROI 2022